Cleared Traditional

K133936 - ARTUS C. DIFFICILE QS-RGQ MDX KIT (FDA 510(k) Clearance)

Apr 2014
Decision
102d
Days
Class 2
Risk

K133936 is an FDA 510(k) clearance for the ARTUS C. DIFFICILE QS-RGQ MDX KIT. This device is classified as a C. Difficile Toxin Gene Amplification Assay (Class II - Special Controls, product code OZN).

Submitted by QIAGEN GmbH (Gaithersburg, US). The FDA issued a Cleared decision on April 4, 2014, 102 days after receiving the submission on December 23, 2013.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3130. Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients..

Submission Details

510(k) Number K133936 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2013
Decision Date April 04, 2014
Days to Decision 102 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code OZN — C. Difficile Toxin Gene Amplification Assay
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3130
Definition Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients.